Chembio Diagnostics Investor Relations Material
Latest events
Q3 2022
Chembio Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Chembio Diagnostics Inc
Access all reports
Chembio Diagnostics Inc. is a biotechnology company specializing in the development, manufacturing, and commercialization of point-of-care diagnostic products. The company focuses on delivering diagnostic solutions for infectious diseases and other medical conditions. Its offerings utilize proprietary technologies to provide rapid, accurate results in healthcare settings, aiming to support clinical decision-making and public health efforts. Its portfolio encompasses diagnostic assays, devices, and related components tailored to specific testing requirements. Chembio Diagnostics Inc. is headquartered in Hauppauge, New York, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CEMI
Country
🇺🇸 United States